From: A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma
MVA | HR | 95% CI | P-value |
---|---|---|---|
Age | |||
 65–69.9 | Reference | 0.002 | |
 70–74.9 | 1.179 | 0.704–1.972 | 0.532 |
 75–79.9 | 1.53 | 0.892–2.626 | 0.123 |
 > 80 years | 2.878 | 1.651–5.017 | < 0.001 |
MGMT | |||
 methylated | Reference |  | |
 unknown or non-methylated | 1.91 | 1.147–3.180 | 0.013 |
KPS | |||
 90–100% | Reference | 0.005 | |
 70–80% | 0.85 | 0.534–1.351 | 0.491 |
 50–60% | 1.949 | 1.104–3.439 | 0.021 |
 10–40% | 4.433 | 0.92–21.352 | 0.063 |
EOR | |||
 GTR | Reference | 0.275 | |
 STR | 1.331 | 0.855–2.072 | 0.205 |
 Biopsy | 1.567 | 0.868–2.830 | 0.136 |
Motor deficits after surgery | |||
 no motor deficit | Reference |  | |
 any motor deficit | 1.117 | 0.727–1.715 | 0.615 |
Aphasia after surgery | |||
 no aphasia | Reference |  | |
 aphasia | 1.466 | 0.907–2.370 | 0.118 |